Louis Düring

Louis Düring is a highly experienced Senior Scientist currently at Novo Nordisk since August 2022, with prior expertise as an Upstream Process Development Scientist at AGC Biologics and significant contributions at Evolva Group in developing the biosynthetic pathway for Stevia. Academic training includes a PhD in Molecular Biology and a cand scient degree in Biochemistry from the University of Copenhagen, along with early research insight into DNA repair mechanisms at Columbia University. Notable achievements include optimizing mammalian and microbial processes, strain engineering, and working on splicing deficient yeast strains, demonstrating a strong background in molecular biology and bioprocess development.